{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:11:40Z","timestamp":1788754300893,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008368","name":"Arthritis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005747","name":"AP M\u00f8ller and Chastine McKinney M\u00f8ller Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007606","name":"Aarhus University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010078","name":"Central Jutland Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010078","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase and Ejnar Danielsens Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008249","name":"Frimodt Henike Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010983","name":"Health Research Foundation of Central Denmark Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010983","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.semarthrit.2026.153039","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:42:16Z","timestamp":1782888136000},"page":"153039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Predictors of relapse, early escalation and 1-Year use of glucocorticoids in new-onset polymyalgia rheumatica: A prospective cohort study"],"prefix":"10.1016","volume":"80","author":[{"given":"Tobias B","family":"Kokholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas W","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ib T","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6291-157X","authenticated-orcid":false,"given":"Berit D","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Blegvad-Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren G","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen-Margrethe","family":"Hauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kresten K","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semarthrit.2026.153039_bib0001","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joim.13525","article-title":"An update on polymyalgia rheumatica","volume":"292","author":"Lundberg","year":"2022","journal-title":"J Intern Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153039_bib0002","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/21678707.2016.1244480","article-title":"Managing of giant cell arteritis and polymyalgia rheumatica","volume":"4","author":"Gonz\u00e1lez-Gay","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153039_bib0003","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0049-0172(84)90012-X","article-title":"Long-term follow-up of polymyalgia rheumatica: evidence for synovitis","volume":"13","author":"Healey","year":"1984","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153039_bib0004","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41584-020-0458-5","article-title":"Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica","volume":"16","author":"Camellino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153039_bib0005","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153039_bib0006","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3899\/jrheum.110977","article-title":"Patient-reported outcomes in polymyalgia rheumatica","volume":"39","author":"Matteson","year":"2012","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153039_bib0007","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2474-12-94","article-title":"The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity","volume":"12","author":"Cimmino","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153039_bib0008","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/ard.2009.114579","article-title":"Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases","volume":"69","author":"van der Goes","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"10.1016\/j.semarthrit.2026.153039_bib0009","doi-asserted-by":"crossref","first-page":"E680","DOI":"10.1503\/cmaj.190178","article-title":"Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England","volume":"191","author":"Wu","year":"2019","journal-title":"Cmaj"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153039_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001220","article-title":"Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis","volume":"8","author":"Wu","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.semarthrit.2026.153039_bib0011","article-title":"Repeated short corticotropin testing in patients with polymyalgia rheumatica","author":"Gaster","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153039_bib0012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10067-021-05819-z","article-title":"Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis","volume":"41","author":"Floris","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153039_bib0013","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.20901","article-title":"Acute-phase reactants and the risk of relapse\/recurrence in polymyalgia rheumatica: a prospective followup study","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153039_bib0014","first-page":"1326","article-title":"The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study","volume":"26","author":"Gonz\u00e1lez-Gay","year":"1999","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.153039_bib0015","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/ard.52.12.847","article-title":"The clinical and laboratory course of polymyalgia rheumatica\/giant cell arteritis after the first two months of treatment","volume":"52","author":"Kyle","year":"1993","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153039_bib0016","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/14397595.2015.1071304","article-title":"MMP-3 can distinguish isolated PMR from PMR with GCA: a retrospective study regarding PMR and GCA in Japan","volume":"26","author":"Fukui","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153039_bib0017","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00296-017-3874-3","article-title":"Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database","volume":"38","author":"Albrecht","year":"2018","journal-title":"Rheumatol Int"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153039_bib0018","first-page":"1945","article-title":"Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis","volume":"26","author":"Narv\u00e1ez","year":"1999","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153039_bib0019","article-title":"Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR Cohort Study","volume":"6","author":"Muller","year":"2022","journal-title":"Rheumatol Adv Pract"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153039_bib0020","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3899\/jrheum.180324","article-title":"Permanent discontinuation of glucocorticoids in Polymyalgia Rheumatica is uncommon but may Be enhanced by amino bisphosphonates","volume":"46","author":"Giollo","year":"2019","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153039_bib0021","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/14397595.2020.1777680","article-title":"Predictors of long-term therapy with glucocorticoid in polymyalgia rheumatica","volume":"31","author":"Aoki","year":"2021","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153039_bib0022","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00296-012-2580-4","article-title":"Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR)","volume":"33","author":"Lee","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2026.153039_bib0023","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1007\/s10238-022-00976-0","article-title":"Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica","volume":"23","author":"Perricone","year":"2022","journal-title":"Clin Exp Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153039_bib0024","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/kep395","article-title":"Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study","volume":"49","author":"Mackie","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153039_bib0025","first-page":"502","article-title":"Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica","volume":"29","author":"Amoli","year":"2002","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153039_bib0026","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/sarh.2002.50025","article-title":"Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica","volume":"33","author":"Gonz\u00e1lez-Gay","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153039_bib0027","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s00259-024-06697-8","article-title":"The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET\/CT in polymyalgia rheumatica\u2014a prospective study of 101 patients","volume":"51","author":"Nielsen","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153039_bib0028","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/ard.2003.011379","article-title":"A disease activity score for polymyalgia rheumatica","volume":"63","author":"Leeb","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153039_bib0029","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.semarthrit.2026.153039_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153039_bib0031","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/bimj.200710415","article-title":"Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection","volume":"50","author":"Ruopp","year":"2008","journal-title":"Biom J"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153039_bib0032","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","article-title":"Receiver operating characteristic curve analysis in diagnostic accuracy studies: a guide to interpreting the area under the curve value","volume":"23","author":"\u00c7orbac\u0131o\u011flu","year":"2023","journal-title":"Turk J Emerg Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153039_bib0033","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.22777","article-title":"Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica","volume":"57","author":"Hutchings","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153039_bib0034","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF02208345","article-title":"The CRP initial response to treatment as prognostic factor in patients with polymyalgia rheumatica","volume":"14","author":"Schreiber","year":"1995","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153039_bib0035","first-page":"1750","article-title":"Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica","volume":"25","author":"Gonz\u00e1lez-Gay","year":"1998","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153039_bib0036","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ard-2023-224543","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","volume":"83","author":"Dejaco","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153039_bib0037","article-title":"Low incidence of late-onset giant cell arteritis during the first year in patients with polymyalgia rheumatica-a repeated imaging study","author":"Nielsen","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153039_bib0038","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.semarthrit.2018.05.007","article-title":"Predictors of positive (18)F-FDG PET\/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica","volume":"48","author":"Prieto-Pe\u00f1a","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153039_bib0039","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00259-018-4106-0","article-title":"Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET\/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study","volume":"46","author":"Nielsen","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153039_bib0040","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/1756-185X.13978","article-title":"Predictors of glucocorticoid-free remission in patients with polymyalgia rheumatica treated with prednisolone","volume":"23","author":"Hattori","year":"2020","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153039_bib0041","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/1744666X.2021.1890032","article-title":"Predicting the risk of relapse in polymyalgia rheumatica: novel insights","volume":"17","author":"Prieto-Pe\u00f1a","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153039_bib0042","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/030097401753180327","article-title":"Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients","volume":"30","author":"Myklebust","year":"2001","journal-title":"Scand J Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:02:01Z","timestamp":1788753721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0049017226001290"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153039","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of relapse, early escalation and 1-Year use of glucocorticoids in new-onset polymyalgia rheumatica: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153039"}}